Boston, MA — June 5, 2025 — Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver faster, more accurate, and fully compliant multilingual communications across 150+ languages.
Built by industry veterans, Sesen is redefining how global life sciences companies manage language workflows—from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT, a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content.
Key Capabilities Include:
- Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines
- ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management
- AI-enabled hybrid workflows for clinical trial translations, pharmacovigilance, and labeling
- Native linguists and MD/PhD medical reviewers for domain-specific accuracy
- Scalable language solutions integrated with sponsor CMS and eTMF systems
“Life sciences innovation is increasingly global, but language remains a critical barrier,” said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy at Sesen. “We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands.”
Diego
Di Leva, Sesen’s
VP of Global Operations and Strategic Partnership, and a certified ISO 9001 and
ISO 13485 auditor, added:
"At Sesen, language
quality is not an afterthought—it’s built into the DNA of every project. Our
quality assurance framework is grounded in international standards and
supported by linguists with deep domain expertise, ensuring every deliverable
meets the highest regulatory and scientific expectations."
With a growing network of professional linguists, in-country reviewers, and regulatory consultants, Sesen is already supporting top-10 pharmaceutical and biotechnology companies with compliant, on-time delivery of multilingual assets for global product launches, international clinical trials, and worldwide regulatory submissions.
To learn more about Sesen or to request a quote, visit www.sesen.com.
Media Contact:
Nikki Andrews
press@sesen.com
About Sesen
Sesen is a specialized language solutions provider exclusively serving the life
sciences industry. With a focus on clinical, regulatory, and commercial
translation services, Sesen supports pharmaceutical, biotech, medical device,
and CRO clients in over 150 languages. The company combines expert native
linguists, medical professionals, and ISO-certified workflows with proprietary
AI technology to deliver faster, more accurate, and fully compliant
multilingual content. From global clinical trial support to in-market product
localization, Sesen enables life sciences organizations to operate with
linguistic confidence and regulatory precision worldwide.
